Publications
861
Citations
23,172
Est. group size
~41
Recurring co-author estimate
Active years
31
Publishing since 1996
Marcos de Lima works on treatments for blood cancers such as leukemia and lymphoma, with a focus on stem cell (bone marrow) transplantation and CAR T-cell therapy, which involves engineering a patient's own immune cells to attack cancer. His work frequently draws on large multi-center patient registries (such as CIBMTR) to study transplant outcomes, drug safety, and complications of cell-based therapies.
Publication output has fluctuated over the last decade with a peak around 2023, but has settled to a somewhat lower and steady pace in the most recent years.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Outcomes of allogeneic HCT in Hodgkin lymphoma in the era of checkpoint inhibitors: a joint CIBMTR and EBMT analysis
Blood · 2025
- Treatment of non-Hodgkin lymphoma with point-of-care manufactured CAR T cells: a dual institution, phase 1 trial
EClinicalMedicine · 2025
- <scp>CD19 CAR</scp> T‐Cell Therapy for Primary Mediastinal Large B‐Cell Lymphoma: A <scp>CIBMTR</scp> Analysis
American Journal of Hematology · 2025
- Five‐Year Real‐World Safety of Inotuzumab Ozogamicin Before Hematopoietic Stem Cell Transplantation in B‐Cell Precursor Acute Lymphoblastic Leukemia
American Journal of Hematology · 2025
- CIBMTR Registry Data on Inotuzumab Ozogamicin Treatment in Patients with ALL Who Proceeded to Hematopoietic Stem Cell Transplant—A Podcast
Targeted Oncology · 2025
- Allogeneic haematopoietic cell transplantation in advanced systemic mastocytosis in the new era: A <scp>CIBMTR</scp> study
British Journal of Haematology · 2025
- Challenges and considerations in developing trispecific CAR-Ts for B-cell malignancies
Expert Opinion on Biological Therapy · 2025
- O IMPACTO DA PANDEMIA COVID-19 NO CENÁRIO DE TRABALHO DA EQUIPE DE ENFERMAGEM: uma revisão integrativa da literatura
Revista Multidisciplinar do Nordeste Mineiro · 2025
- Apresentação do v. 19, n. 1 da Travessias
Travessias · 2025
- Eficácia da terapia fotodinâmica antimicrobiana (aPDT) com Azul de metileno no tratamento da osteonecrose dos maxilares
Contribuciones a las Ciencias Sociales · 2025
- IMMUNE EFFECTOR CELL-ASSOCIATED HLH IN HIGH TUMOR BURDEN PATIENTS TREATED WITH CAR-T: LESSONS FROM BRAZILIAN CASES
Hematology Transfusion and Cell Therapy · 2025
- Total marrow irradiation-based, intensified reduced-intensity conditioning regimen for haploidentical hematopoietic cell transplantation with posttransplant cyclophosphamide: A prospective study
Blood · 2025
- Outcomes of people living with acute lymphoblastic leukemia who received inotuzumab ozogamicin before a stem cell transplant: a plain language summary
Future Oncology · 2025
- Desafíos en el manejo de la diabetes en Venezuela
Revista de la Sociedad venezolana de endocrinologia y metabolismo · 2025
- Siltuximab for chimeric antigen receptor T-cell therapy–related CRS and ICANS: a multicenter retrospective analysis
Blood Advances · 2024
- Blood×99
- Biology of Blood and Marrow Transplantation×57
- Transplantation and Cellular Therapy×29
- Bone Marrow Transplantation×24
- Clinical Lymphoma Myeloma & Leukemia×15
- Ayman Saad
Medicine · The Ohio State University
- Hannah Choe
Medicine · The Ohio State University
- Julianna Roddy
Medicine · The Ohio State University
- Brandon M. Triplett
Medicine · Purdue University West Lafayette
- Sarah Wall
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile